S3 Ventures
VC Fund
Austin, United States
S3 Ventures is a venture capital firm that helps entrepreneurs in building high-impact companies. The company provides patient capital and substantial resources to visionary entrepreneurs, enabling them to nurture exceptional, high-impact businesses in the fields of business technology, digital experiences, and healthcare technology.
- Total investments:
- 144
- Last investment:
- Lead investor:
- 55%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries S3 Ventures invests in
Stages S3 Ventures invests in
Countries S3 Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.5M–$8.2M
- Series A
- $4.4M–$20M
- Series B
- $5.5M–$42M
Investment Focus
Industry
- Software 31 (22%)
- Information Technology 15 (10%)
- SaaS 12 (8%)
- Health Care 8 (6%)
- Medical Device 6 (4%)
Stage
- Series A 29 (20%)
- Seed 24 (17%)
- Series B 24 (17%)
- Series C 11 (8%)
- Funding Round 11 (8%)
Country
- United States 64 (44%)
- Canada 1 (1%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aaron Perman
General Partner
|
General Partner | Total investments: 16 | Find email | |
Alex Marty
Associate
|
Associate | Total investments: 0 | Find email | |
Charlie Plauche
General Partner
|
General Partner | Total investments: 26 | Find email | |
Cole Bonner
Senior Associate
|
Senior Associate | Total investments: 1 | Find email | |
Eric Engineer
General Partner
|
General Partner | Total investments: 15 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Buzz Solutions
|
Buzz Solutions provides a software platform powered by Artificial Intelligence, Actionable Insights, and Predictive Analytics for faults and anomaly detection for the power line inspection process for power utilities. The company's platform automates the process of storing and organizing visual data (captured in the field through drones andhelicopters), analyzing for faults using its AI algorithms, mapping the data and providing heat maps as well as predictive insights for when, where and what kind of faults are happening on power line and assets. Using its solutions, power utilities save over 50% of cost and time to analyze data which makes condition-based maintenance efforts easier and time-efficient, thus, preventing wildfires, power outages, and other climate change effects on the physical infrastructure of the grid. | $20M / Series A / Aug 04, 2026 | |
DataBahn
|
DataBahn provides an AI-powered platform designed for smarter data pipeline management, enabling the collection, integration, routing, and optimization of telemetry data with high precision and minimal friction. The platform assists organizations in securely collecting, enriching, orchestrating, and optimizing their enterprise data, focusing onenhancing information security and operational efficacy. By eliminating fragmented toolchains and reducing operational overhead, DataBahn delivers real-time insights, intelligent automation and immediate ROI—without added complexity. | $40M / Series B / Jul 30, 2026 | |
Buildforce
|
Buildforce is building the first-ever marketplace and career lifecycle platform for people in construction, starting with the electrical trade. Its end-to-end career platform enables people in the construction trades to maintain consistent work at fair pay and with the benefits of a W-2 employee. Since its launch in 2020, Buildforce has become thego-to partner helping dozens of construction contractors connect with the construction workforce. | $10M / Series A / Jul 28, 2026 | |
RapidPulse
|
RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry | $48M / Series B / Jul 16, 2026 | |
Vendelux
|
Vendelux is the leading Event Intelligence Platform that helps marketers make more data-driven decisions around event attendance, sponsorship, and hosting. Customers match CRM data against a proprietary database of over 30,000 events, including speaker, sponsor, and attendee information, to easily find their prospects, customers, and competitorseverywhere they are going to be. | $50M / Series B / Jul 08, 2026 | |
Earlytrade
|
Earlytrade creates a positive change in the way businesses get paid and delivers a powerful two-fold effect.By incentivising early payment, suppliers are in control of when they get paid. Removing the need to pursue other funding options and accrue more debt.Corporate customers deepen their relationships with satisfied suppliers and arerewarded with higher margins. | $10M / Series A / Jun 09, 2026 | |
Arpio
|
Arpio protects and eliminates downtime for AWS applications by making it easy to recover from any outage in just a few minutes. Founded by Doug Neumann and Shaw Terwilliger in 2018 and is based in Durham, North Carolina, United States. | $15M / Series A / Jun 03, 2026 | |
Advanced NanoTherapies
|
We create nanoparticle technologies that enable and improve drug uptake and retention into the cell for medical devices. | $31M / Series B / Jun 02, 2026 | |
Schematic
|
Schematic allows businesses to outsource pricing and packaging with a few lines of code, enabling them to quickly launch new packaging models, take the burden off of engineering, and flexibly adjust their pricing and packaging to individual customer preferences. The platform enhances existing billing systems like Stripe by offering tools formanaging pricing, entitlements, and usage-based metering. This allows SaaS businesses to efficiently handle subscriptions, plan updates, and customer access to features without the need for extensive custom-built solutions. | $6.5M / Seed / Apr 21, 2026 | |
Endovascular Engineering
|
Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis. | $80M / Series C / Apr 07, 2026 | |
| See all 144 investments → | |||
Co-Investors
Triangle Tweener Fund
9 deals together
Next Coast Ventures
7 deals together
Brick & Mortar Ventures
6 deals together
Creative Co Capital
6 deals together
Alerion Ventures
5 deals together
Argonaut Private Equity
5 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does S3 Ventures invest in?
S3 Ventures invests primarily in Software, Information Technology and SaaS startups, most often at Series A and Seed stage. Most of the 144 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is S3 Ventures's check size?
S3 Ventures typically joins rounds of $1.5M–$8.2M at Seed, $4.4M–$20M at Series A and $5.5M–$42M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds S3 Ventures participates in.
How do I contact S3 Ventures?
Public channels for S3 Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at S3 Ventures?
The team at S3 Ventures includes Aaron Perman (General Partner), Alex Marty (Associate) and Charlie Plauche (General Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
